This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Health Technology Remove healthcare technology Remove Pharmaceuticals Remove Remote care
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

NOVEMBER 25, 2023

This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.

Pharmaceuticals 64
Pharmaceuticals Pain management Chronic pain management Mental health 64
article thumbnail

Why have billion dollar digital health companies struggled since the pandemic?

Lloyd Price

MAY 6, 2023

There were 368 deals in the digital health space in 2018, with an average deal size of $22.2 The largest funding rounds in 2018 went to companies working on healthcare technology solutions such as Rhythm Pharmaceuticals, which raised $151 million, and Modernizing Medicine, which raised $231 million.

Digital Health 95
Digital Health Mental health Telemedicine healthcare technology 95
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 82,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024